European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies.

• Annese V University Hospital Careggi, Department of Gastroenterology, Florence, Italy annesev@aou-careggi.toscana.it.
• Beaugerie L Department of Gastroenterology, AP-HP Hôpital Saint-Antoine, and UPMC Univ Paris 06, Paris, France.
• Egan L Pharmacology and Therapeutics, School of Medicine, National University of Ireland, Galway, Ireland.
• Biancone L University Tor Vergata of Rome, GI Unit, Department of Systems Medicine, Rome, Italy.
• Bolling C Agaplesion Markus Krankenhaus, Medizinische Klinik I, Frankfurt am Main, Germany.
• Brandts C Department of Medicine, Hematology/Oncology, Goethe University, Frankfurt am Main, Germany.
• Dierickx D Department of Haematology, University Hospital Leuven, Leuven, Belgium.
• Dummer R Department of Dermatology, University Zürich, Zürich, Switzerland.
• Fiorino G Gastroenterology Department, Humanitas Research Hospital, Rozzano, Italy.
• Gornet JM Service d'hépatogastroentérologie, Hopital Saint-Louis, Paris, France.
• Higgins P University of Michigan, Department of Internal Medicine, Ann Arbor, USA.
• Katsanos KH Department of Gastroenterology, Medical School, University of Ioannina, Ioannina, Greece.
• Nissen L Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
• Pellino G Second University of Naples, Unit of Colorectal Surgery, Department of Medical, Surgical, Neurological, Metabolic and Ageing Sciences, Naples, Italy.
• Rogler G Klinik für Gastroenterologie und Hepatologie, UniversitätsSpital Zürich, Zürich, Switzerland.
• Scaldaferri F Università Cattolica del Sacro Cuore, Department of Internal Medicine, Gastroenterology Division, Roma, Italy.
• Szymanska E Department of Pediatrics, Nutrition and Metabolic Disorders, Children's Memorial Health Institute, Warsaw, Poland.
• Eliakim R Department of Gastroenterology and Hepatology, Sheba Medical Center & Sackler School of Medicine, Israel.

Show more…

Europe

Evidence-Based Medicine

Humans

Inflammatory Bowel Diseases

Neoplasms

Prognosis

Risk Factors